ADC Therapeutics SA (NYSE:ADCT)

3.59
Delayed Data
As of 4:00pm ET
 +0.11 / +3.16%
Today’s Change
3.31
Today|||52-Week Range
23.28
-82.23%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for ADC Therapeutics SA have a median target of 7.00, with a high estimate of 21.00 and a low estimate of 5.00. The median estimate represents a +94.99% increase from the last price of 3.59.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in ADC Therapeutics SA. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.53
Sales
$56.6M
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 18.08%
 
 
 
 
 
 
Growthannually 23.17%
 
 
 
 

Sales

Growthquarterly -25.81%
 
 
 
 
 
 
Growthannually 460.77%
 
 
 
 
Key to the earnings and sales forecast charts.